Business Context and Reporting Period
This Form 6-K filing by Therapix Biosciences Ltd. (not Scisparc Ltd.) covers the month of September 2020, specifically dated September 10, 2020. The document reports on a corporate governance event regarding a Special General Meeting of Shareholders.
Financial Metrics
The filing text does not provide a clear value for revenue, profit, cash flow, margins, debt, or liquidity. This report is a procedural notice and contains no financial statements or performance data.
Material Changes
There are no material financial changes reported. The only material event is the adjournment of the Special General Meeting of Shareholders originally convened on September 10, 2020, due to a lack of quorum.
Outlook and Management Commentary
The Company announced that the Special General Meeting will be reconvened on Thursday, September 17, 2020, at 4:00 p.m. (Israel time). The meeting will be held at the offices of Meitar Law Offices, 16 Abba Hillel Silver Rd., Ramat Gan 5250608, Israel. The filing notes that this report is incorporated by reference into the Company's registration statements on Form F-3 and Form S-8.
Key Facts for Investor Verification
- The Special General Meeting of Shareholders was adjourned on September 10, 2020, due to a lack of quorum.
- The meeting is rescheduled for September 17, 2020, at the same time and location.
- This filing contains no financial performance data or guidance.
- The registrant is Therapix Biosciences Ltd., an Israeli company filing under Form 20-F.